The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Multiple myeloma
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
Rajkumar, S. V., Dimopoulos, M. A., Palumbo, A., Blade, J., Merlini, G., Mateos, M.-V., Kumar, S., Hillengass, J., Kastritis, E., Richardson, P., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70442-5 · Cited by 4,978
Self-citationmiR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
Kumar, S., Paiva, B., Anderson, K. C., Durie, B., Landgren, O., Moreau, P., Munshi, N., Lonial, S., Bladé, J., Mateos, M.-V., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30206-6 · Cited by 3,061
Self-citationInternational Staging System for Multiple Myeloma
Greipp, P. R., Miguel, J. S., Durie, B. G. M., Crowley, J. J., Barlogie, B., Bladé, J., Boccadoro, M., Child, J. A., Avet-Loiseau, H., Kyle, R. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.242 · Cited by 2,974
Self-citationSelective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Lovén, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.036 · Cited by 2,961
Attal, M., Harousseau, J.-L., Stoppa, A.-M., Sotto, J.-J., Fuzibet, J.-G., Rossi, J.-F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607113350204 · Cited by 2,548
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
Kyle, R. A., Gertz, M. A., Witzig, T. E., Lust, J. A., Lacy, M. Q., Dispenzieri, A., Fonseca, R., Rajkumar, S. V., Offord, J. R., Larson, D. R., et al. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.1.21 · Cited by 2,447
Self-citationPalumbo, A., Avet-Loiseau, H., Oliva, S., Lokhorst, H. M., Goldschmidt, H., Rosinol, L., Richardson, P., Caltagirone, S., Lahuerta, J. J., Facon, T., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.2267 · Cited by 2,210
Self-citationBortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
San Miguel, J. F., Schlag, R., Khuageva, N. K., Dimopoulos, M. A., Shpilberg, O., Kropff, M., Spicka, I., Petrucci, M. T., Palumbo, A., Samoilova, O. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801479 · Cited by 1,899
Self-citationLenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Krönke, J., Udeshi, N. D., Narla, A., Grauman, P., Hurst, S. N., McConkey, M., Svinkina, T., Heckl, D., Comer, E., Li, X., et al. (2014) · Science · doi:10.1126/science.1244851 · Cited by 1,879
Cell cycle proteins as promising targets in cancer therapy
Otto, T., & Sicinski, P. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.138 · Cited by 1,858
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
Child, J. A., Morgan, G. J., Davies, F. E., Owen, R. G., Bell, S. E., Hawkins, K., Brown, J., Drayson, M. T., & Selby, P. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022340 · Cited by 1,768
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Lu, G., Middleton, R. E., Sun, H., Naniong, M., Ott, C. J., Mitsiades, C. S., Wong, K.-K., Bradner, J. E., & Kaelin, W. G. (2014) · Science · doi:10.1126/science.1244917 · Cited by 1,583
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
Palumbo, A., Chanan-Khan, A., Weisel, K., Nooka, A. K., Masszi, T., Beksac, M., Spicka, I., Hungria, V., Munder, M., Mateos, M. V., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606038 · Cited by 1,522
Self-citationA Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance
Kyle, R. A., Therneau, T. M., Rajkumar, S. V., Offord, J. R., Larson, D. R., Plevak, M. F., & Melton, L. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa01133202 · Cited by 1,475
Self-citationDaratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Dimopoulos, M. A., Oriol, A., Nahi, H., San-Miguel, J., Bahlis, N. J., Usmani, S. Z., Rabin, N., Orlowski, R. Z., Komarnicki, M., Suzuki, K., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607751 · Cited by 1,445
Kumar, S. K., Dispenzieri, A., Lacy, M. Q., Gertz, M. A., Buadi, F. K., Pandey, S., Kapoor, P., Dingli, D., Hayman, S. R., Leung, N., et al. (2014) · Leukemia · doi:10.1038/leu.2013.313 · Cited by 1,369
Self-citationKyle, R. A., & Rajkumar, S. V. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041875 · Cited by 1,296
Self-citationLenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma
Mateos, M.-V., Hernández, M.-T., Giraldo, P., de la Rubia, J., de Arriba, F., Corral, L. L., Rosiñol, L., Paiva, B., Palomera, L., Bargay, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300439 · Cited by 1,171
Self-citationLenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
Attal, M., Lauwers-Cances, V., Marit, G., Caillot, D., Moreau, P., Facon, T., Stoppa, A. M., Hulin, C., Benboubker, L., Garderet, L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114138 · Cited by 1,155
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
McCarthy, P. L., Owzar, K., Hofmeister, C. C., Hurd, D. D., Hassoun, H., Richardson, P. G., Giralt, S., Stadtmauer, E. A., Weisdorf, D. J., Vij, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114083 · Cited by 1,147
Self-citationThe molecular classification of multiple myeloma
Zhan, F., Huang, Y., Colla, S., Stewart, J. P., Hanamura, I., Gupta, S., Epstein, J., Yaccoby, S., Sawyer, J., Burington, B., et al. (2006) · Blood · doi:10.1182/blood-2005-11-013458 · Cited by 1,133
Landgren, O., Kyle, R. A., Pfeiffer, R. M., Katzmann, J. A., Caporaso, N. E., Hayes, R. B., Dispenzieri, A., Kumar, S., Clark, R. J., Baris, D., et al. (2009) · Blood · doi:10.1182/blood-2008-12-194241 · Cited by 1,127
Self-citationTargeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
Lokhorst, H. M., Plesner, T., Laubach, J. P., Nahi, H., Gimsing, P., Hansson, M., Minnema, M. C., Lassen, U., Krejcik, J., Palumbo, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506348 · Cited by 1,117
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
Lohr, J. G., Stojanov, P., Carter, S. L., Cruz-Gordillo, P., Lawrence, M. S., Auclair, D., Sougnez, C., Knoechel, B., Gould, J., Saksena, G., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.015 · Cited by 988
Self-citationEuropean Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
Terpos, E., Kleber, M., Engelhardt, M., Zweegman, S., Gay, F., Kastritis, E., van de Donk, N. W. C. J., Bruno, B., Sezer, O., Broijl, A., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.117176 · Cited by 988
Self-citationPromiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983
Self-citationAnnunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.004 · Cited by 952
Rajkumar, S. V., Jacobus, S., Callander, N. S., Fonseca, R., Vesole, D. H., Williams, M. E., Abonour, R., Siegel, D. S., Katz, M., & Greipp, P. R. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70284-0 · Cited by 933
Self-citationSonneveld, P., Avet-Loiseau, H., Lonial, S., Usmani, S., Siegel, D., Anderson, K. C., Chng, W.-J., Moreau, P., Attal, M., Kyle, R. A., et al. (2016) · Blood · doi:10.1182/blood-2016-01-631200 · Cited by 928
Self-citationClinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma
Kyle, R. A., Remstein, E. D., Therneau, T. M., Dispenzieri, A., Kurtin, P. J., Hodnefield, J. M., Larson, D. R., Plevak, M. F., Jelinek, D. F., Fonseca, R., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070389 · Cited by 921
Self-citationShaughnessy, J. D., Zhan, F., Burington, B. E., Huang, Y., Colla, S., Hanamura, I., Stewart, J. P., Kordsmeier, B., Randolph, C., Williams, D. R., et al. (2007) · Blood · doi:10.1182/blood-2006-07-038430 · Cited by 914
The genetic architecture of multiple myeloma
Morgan, G. J., Walker, B. A., & Davies, F. E. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3257 · Cited by 913
Durie, B. G. M., Hoering, A., Abidi, M. H., Rajkumar, S. V., Epstein, J., Kahanic, S. P., Thakuri, M., Reu, F., Reynolds, C. M., Sexton, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31594-x · Cited by 908
Self-citationDamiano, J. S., Cress, A. E., Hazlehurst, L. A., Shtil, A. A., & Dalton, W. S. (1999) · Blood · doi:10.1182/blood.v93.5.1658 · Cited by 901
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Bolli, N., Avet-Loiseau, H., Wedge, D. C., Van Loo, P., Alexandrov, L. B., Martincorena, I., Dawson, K. J., Iorio, F., Nik-Zainal, S., Bignell, G. R., et al. (2014) · Nature Communications · doi:10.1038/ncomms3997 · Cited by 875
Self-citationFacon, T., Mary, J. Y., Hulin, C., Benboubker, L., Attal, M., Pegourie, B., Renaud, M., Harousseau, J. L., Guillerm, G., Chaleteix, C., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61537-2 · Cited by 869
Sonneveld, P., Schmidt-Wolf, I. G. H., van der Holt, B., el Jarari, L., Bertsch, U., Salwender, H., Zweegman, S., Vellenga, E., Broyl, A., Blau, I. W., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.6820 · Cited by 824
Self-citationCavo, M., Tacchetti, P., Patriarca, F., Petrucci, M. T., Pantani, L., Galli, M., Di Raimondo, F., Crippa, C., Zamagni, E., Palumbo, A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61424-9 · Cited by 819
Causes and consequences of aneuploidy in cancer
Gordon, D. J., Resio, B., & Pellman, D. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3123 · Cited by 815
Palumbo, A., Bringhen, S., Caravita, T., Merla, E., Capparella, V., Callea, V., Cangialosi, C., Grasso, M., Rossini, F., Galli, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68338-4 · Cited by 809
Preston, D. L., Kusumi, S., Tomonaga, M., Izumi, S., Ron, E., Kuramoto, A., Kamada, N., Dohy, H., Matsui, T., Nonaka, H., et al. (1994) · Radiation Research · doi:10.2307/3578893 · Cited by 803
BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
Roccaro, A. M., Sacco, A., Maiso, P., Azab, A. K., Tai, Y.-T., Reagan, M., Azab, F., Flores, L. M., Campigotto, F., Weller, E., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66517 · Cited by 794
Self-citationLenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma
Benboubker, L., Dimopoulos, M. A., Dispenzieri, A., Catalano, J., Belch, A. R., Cavo, M., Pinto, A., Weisel, K., Ludwig, H., Bahlis, N., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402551 · Cited by 793
Self-citationAutologous Transplantation and Maintenance Therapy in Multiple Myeloma
Palumbo, A., Cavallo, F., Gay, F., Di Raimondo, F., Ben Yehuda, D., Petrucci, M. T., Pezzatti, S., Caravita, T., Cerrato, C., Ribakovsky, E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402888 · Cited by 778
Self-citationIRF4 addiction in multiple myeloma
Shaffer, A. L., Emre, N. C. T., Lamy, L., Ngo, V. N., Wright, G., Xiao, W., Powell, J., Dave, S., Yu, X., Zhao, H., et al. (2008) · Nature · doi:10.1038/nature07064 · Cited by 730
Kumar, S. K., Lee, J. H., Lahuerta, J. J., Morgan, G., Richardson, P. G., Crowley, J., Haessler, J., Feather, J., Hoering, A., Moreau, P., et al. (2012) · Leukemia · doi:10.1038/leu.2011.196 · Cited by 721
Self-citationRajkumar, S. V., Kyle, R. A., Therneau, T. M., Melton, L. J., Bradwell, A. R., Clark, R. J., Larson, D. R., Plevak, M. F., Dispenzieri, A., & Katzmann, J. A. (2005) · Blood · doi:10.1182/blood-2005-03-1038 · Cited by 702
Self-citationClonal competition with alternating dominance in multiple myeloma
Keats, J. J., Chesi, M., Egan, J. B., Garbitt, V. M., Palmer, S. E., Braggio, E., Van Wier, S., Blackburn, P. R., Baker, A. S., Dispenzieri, A., et al. (2012) · Blood · doi:10.1182/blood-2012-01-405985 · Cited by 637
Self-citationIMWG consensus on risk stratification in multiple myeloma
Chng, W. J., Dispenzieri, A., Chim, C.-S., Fonseca, R., Goldschmidt, H., Lentzsch, S., Munshi, N., Palumbo, A., Miguel, J. S., Sonneveld, P., et al. (2014) · Leukemia · doi:10.1038/leu.2013.247 · Cited by 601
Self-citationWalker, B. A., Boyle, E. M., Wardell, C. P., Murison, A., Begum, D. B., Dahir, N. M., Proszek, P. Z., Johnson, D. C., Kaiser, M. F., Melchor, L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.1503 · Cited by 567
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
Pichiorri, F., Suh, S.-S., Ladetto, M., Kuehl, M., Palumbo, T., Drandi, D., Taccioli, C., Zanesi, N., Alder, H., Hagan, J. P., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806202105 · Cited by 563
Genomic complexity of multiple myeloma and its clinical implications
Manier, S., Salem, K. Z., Park, J., Landau, D. A., Getz, G., & Ghobrial, I. M. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.122 · Cited by 560
Molecular Pathogenesis and a Consequent Classification of Multiple Myeloma
Bergsagel, P. L., & Kuehl, W. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.021 · Cited by 556
Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival
Novak, A. J., Darce, J. R., Arendt, B. K., Harder, B., Henderson, K., Kindsvogel, W., Gross, J. A., Greipp, P. R., & Jelinek, D. F. (2004) · Blood · doi:10.1182/blood-2003-06-2043 · Cited by 554
Munshi, N. C., Avet-Loiseau, H., Rawstron, A. C., Owen, R. G., Child, J. A., Thakurta, A., Sherrington, P., Samur, M. K., Georgieva, A., Anderson, K. C., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3160 · Cited by 532
Self-citationBerenson, J., Pflugmacher, R., Jarzem, P., Zonder, J., Schechtman, K., Tillman, J. B., Bastian, L., Ashraf, T., & Vrionis, F. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70008-0 · Cited by 524
Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27
Bouchard, C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5321 · Cited by 502
Mikhael, J. R., Dingli, D., Roy, V., Reeder, C. B., Buadi, F. K., Hayman, S. R., Dispenzieri, A., Fonseca, R., Sher, T., Kyle, R. A., et al. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.01.019 · Cited by 500
Self-citationDimopoulos, M., Kyle, R., Fermand, J.-P., Rajkumar, S. V., San Miguel, J., Chanan-Khan, A., Ludwig, H., Joshua, D., Mehta, J., Gertz, M., et al. (2011) · Blood · doi:10.1182/blood-2010-10-299529 · Cited by 454
Self-citationSoutar, R. L., Lucraft, H. H., Jackson, G., Reece, A. T., Bird, J. M., Low, E., & Samson, D. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04834.x · Cited by 454
Kumar, S., Flinn, I., Richardson, P. G., Hari, P., Callander, N., Noga, S. J., Stewart, A. K., Turturro, F., Rifkin, R., Wolf, J., et al. (2012) · Blood · doi:10.1182/blood-2011-11-395749 · Cited by 446
Self-citationDrayson, M., Tang, L. X., Drew, R., Mead, G. P., Carr-Smith, H., & Bradwell, A. R. (2001) · Blood · doi:10.1182/blood.v97.9.2900 · Cited by 419
Dimopoulos, M. A., Terpos, E., Chanan-Khan, A., Leung, N., Ludwig, H., Jagannath, S., Niesvizky, R., Giralt, S., Fermand, J.-P., Bladé, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.8791 · Cited by 414
Self-citationRacial disparities in incidence and outcome in multiple myeloma: a population-based study
Waxman, A. J., Mink, P. J., Devesa, S. S., Anderson, W. F., Weiss, B. M., Kristinsson, S. Y., McGlynn, K. A., & Landgren, O. (2010) · Blood · doi:10.1182/blood-2010-07-298760 · Cited by 411
Pathogenesis of myeloma bone disease
Roodman, G. D. (2009) · Leukemia · doi:10.1038/leu.2008.336 · Cited by 398
Leung-Hagesteijn, C., Erdmann, N., Cheung, G., Keats, J. J., Stewart, A. K., Reece, D. E., Chung, K. C., & Tiedemann, R. E. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.009 · Cited by 383
Hillengass, J., Fechtner, K., Weber, M.-A., Bäuerle, T., Ayyaz, S., Heiss, C., Hielscher, T., Moehler, T. M., Egerer, G., Neben, K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.5356 · Cited by 381
Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma
Bergsagel, P. L., Chesi, M., Nardini, E., Brents, L. A., Kirby, S. L., & Kuehl, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13931 · Cited by 367
Palumbo, A., Bringhen, S., Ludwig, H., Dimopoulos, M. A., Bladé, J., Mateos, M. V., Rosiñol, L., Boccadoro, M., Cavo, M., Lokhorst, H., et al. (2011) · Blood · doi:10.1182/blood-2011-06-358812 · Cited by 352
Self-citationHazlehurst, L. A., Damiano, J. S., Buyuksal, I., Pledger, W. J., & Dalton, W. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203782 · Cited by 344
Boyd, K. D., Ross, F. M., Chiecchio, L., Dagrada, G. P., Konn, Z. J., Tapper, W. J., Walker, B. A., Wardell, C. P., Gregory, W. M., Szubert, A. J., et al. (2012) · Leukemia · doi:10.1038/leu.2011.204 · Cited by 340
Broyl, A., Hose, D., Lokhorst, H., de Knegt, Y., Peeters, J., Jauch, A., Bertsch, U., Buijs, A., Stevens-Kroef, M., Beverloo, H. B., et al. (2010) · Blood · doi:10.1182/blood-2009-12-261032 · Cited by 329
Self-citationMcMillin, D. W., Delmore, J., Weisberg, E., Negri, J. M., Geer, D. C., Klippel, S., Mitsiades, N., Schlossman, R. L., Munshi, N. C., Kung, A. L., et al. (2010) · Nature Medicine · doi:10.1038/nm.2112 · Cited by 315
Self-citationMicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma
Roccaro, A. M., Sacco, A., Thompson, B., Leleu, X., Azab, A. K., Azab, F., Runnels, J., Jia, X., Ngo, H. T., Melhem, M. R., et al. (2009) · Blood · doi:10.1182/blood-2009-01-198408 · Cited by 312
Self-citationGalm, O., Yoshikawa, H., Esteller, M., Osieka, R., & Herman, J. G. (2003) · Blood · doi:10.1182/blood-2002-06-1735 · Cited by 308
Korde, N., Roschewski, M., Zingone, A., Kwok, M., Manasanch, E. E., Bhutani, M., Tageja, N., Kazandjian, D., Mailankody, S., Wu, P., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2010 · Cited by 307
Activation of an Unfolded Protein Response during Differentiation of Antibody-secreting B Cells
Gass, J. N., Gifford, N. M., & Brewer, J. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205011200 · Cited by 304
A gene expression signature for high-risk multiple myeloma
Kuiper, R., Broyl, A., de Knegt, Y., van Vliet, M. H., van Beers, E. H., van der Holt, B., el Jarari, L., Mulligan, G., Gregory, W., Morgan, G., et al. (2012) · Leukemia · doi:10.1038/leu.2012.127 · Cited by 295
Self-citationPathogenesis beyond the cancer clone(s) in multiple myeloma
Bianchi, G., & Munshi, N. C. (2015) · Blood · doi:10.1182/blood-2014-11-568881 · Cited by 288
Rajkumar, S. V., Mesa, R. A., Fonseca, R., Schroeder, G. S., Plevak, M. F., Dispenzieri, A. A., Lacy, M. Q., Lust, J. A., Witzig, T. E., Gertz, M. A., et al. (2002) · PubMed · Cited by 287
Self-citationChng, W.-J., Huang, G. F., Chung, T. H., Ng, S. B., Gonzalez-Paz, N., Troska-Price, T., Mulligan, G., Chesi, M., Bergsagel, P. L., & Fonseca, R. (2011) · Leukemia · doi:10.1038/leu.2011.53 · Cited by 270
Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics
Kumar, S., Fonseca, R., Ketterling, R. P., Dispenzieri, A., Lacy, M. Q., Gertz, M. A., Hayman, S. R., Buadi, F. K., Dingli, D., Knudson, R. A., et al. (2012) · Blood · doi:10.1182/blood-2011-11-390658 · Cited by 253
Self-citationManagement of treatment-emergent peripheral neuropathy in multiple myeloma
Richardson, P. G., Delforge, M., Beksac, M., Wen, P., Jongen, J. L., Sezer, O., Terpos, E., Munshi, N., Palumbo, A., Rajkumar, S. V., et al. (2012) · Leukemia · doi:10.1038/leu.2011.346 · Cited by 253
Self-citationCella, D., Kallich, J., McDermott, A., & Xu, X. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh235 · Cited by 246
Rajkumar, S. V., Gupta, V, Fonseca, R., Dispenzieri, A., Gonsalves, W. I., Larson, D., Ketterling, R. P., Lust, J. A., Kyle, R. A., & Kumar, S. K. (2013) · Leukemia · doi:10.1038/leu.2013.86 · Cited by 239
Self-citationControl of Autophagic Cell Death by Caspase-10 in Multiple Myeloma
Lamy, L., Ngo, V. N., Emre, N. C. T., Shaffer, A. L., Yang, Y., Tian, E., Nair, V., Kruhlak, M. J., Zingone, A., Landgren, O., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.017 · Cited by 220
Chesi, M., Matthews, G. M., Garbitt, V. M., Palmer, S. E., Shortt, J., Lefebure, M., Stewart, A. K., Johnstone, R. W., & Bergsagel, P. L. (2012) · Blood · doi:10.1182/blood-2012-02-412783 · Cited by 214
Homing of antibody secreting cells
Cyster, J. G. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00041.x · Cited by 210
Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma
González, D., van der Burg, M., García-Sanz, R., Fenton, J. A., Langerak, A. W., González, M., van Dongen, J. J. M., San Miguel, J. F., & Morgan, G. J. (2007) · Blood · doi:10.1182/blood-2007-02-069625 · Cited by 208
Guidelines for supportive care in multiple myeloma 2011
Snowden, J. A., Ahmedzai, S. H., Ashcroft, J., D’Sa, S., Littlewood, T., Low, E., Lucraft, H., Maclean, R., Feyler, S., Pratt, G., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08574.x · Cited by 206
Zannettino, A. C. W., Farrugia, A. N., Kortesidis, A., Manavis, J., To, L. B., Martin, S. K., Diamond, P., Tamamura, H., Lapidot, T., Fujii, N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1687 · Cited by 205
Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades
Kyle, R. A., Therneau, T. M., Rajkumar, S. V., Larson, D. R., Plevak, M. F., & Melton, L. J. (2004) · Cancer · doi:10.1002/cncr.20652 · Cited by 201
Self-citationDNA damage defines sites of recurrent chromosomal translocations in B lymphocytes
Hakim, O., Resch, W., Yamane, A., Klein, I., Kieffer-Kwon, K.-R., Jankovic, M., Oliveira, T., Bothmer, A., Voss, T. C., Ansarah-Sobrinho, C., et al. (2012) · Nature · doi:10.1038/nature10909 · Cited by 195
Mateos, M.-V., Hernández, M.-T., Giraldo, P., de la Rubia, J., de Arriba, F., Corral, L. L., Rosiñol, L., Paiva, B., Palomera, L., Bargay, J., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30124-3 · Cited by 193
Self-citationMyeloma as a model for the process of metastasis: implications for therapy
Ghobrial, I. M. (2012) · Blood · doi:10.1182/blood-2012-01-379024 · Cited by 188
Eichner, R., Heider, M., Fernández-Sáiz, V., van Bebber, F., Garz, A.-K., Lemeer, S., Rudelius, M., Targosz, B.-S., Jacobs, L., Knorn, A.-M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4128 · Cited by 183
Genome-wide association study identifies multiple susceptibility loci for multiple myeloma
Mitchell, J. S., Li, N., Weinhold, N., Försti, A., Ali, M., van Duin, M., Thorleifsson, G., Johnson, D. C., Chen, B., Halvarsson, B.-M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12050 · Cited by 180
Self-citationZhao, J.-J., Lin, J., Zhu, D., Wang, X., Brooks, D., Chen, M., Chu, Z.-B., Takada, K., Ciccarelli, B., Admin, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3311-t · Cited by 177
Self-citationMechanisms of bone lesions in multiple myeloma and lymphoma
Roodman, G. D. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1557::aid-cncr5>3.0.co;2-h · Cited by 164
Agirre, X., Castellano, G., Pascual, M., Heath, S. C., Kulis, M., Segura, V., Bergmann, A. K., Esteve‐Codina, A., Merkel, A., Raineri, E., et al. (2015) · Genome Research · doi:10.1101/gr.180240.114 · Cited by 160
EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors
Pallis, A. G., Ring, A., Fortpied, C., Penninckx, B., Van Nes, M. C., Wedding, U., vonMinckwitz, G., Johnson, C. D., Wyld, L., Timmer-Bonte, A., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq687 · Cited by 158
Vachon, C. M., Kyle, R. A., Therneau, T. M., Foreman, B. J., Larson, D. R., Colby, C. L., Phelps, T. K., Dispenzieri, A. A., Kumar, S. K., Katzmann, J. A., et al. (2009) · Blood · doi:10.1182/blood-2008-12-192575 · Cited by 157
Self-citationMcl‐1 and Bcl‐xL are co‐regulated by IL‐6 in human myeloma cells
Puthier, D., Derenne, S., Barillé‐Nion, S., Moreau, P., Harousseau, J., Bataille, R., & Amiot, M. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01705.x · Cited by 157
Sigurdardottir, E. E., Turesson, I., Lund, S. H., Lindqvist, E. K., Mailankody, S., Korde, N., Björkholm, M., Landgren, O., & Kristinsson, S. Y. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.23 · Cited by 153
Turesson, I., Vélez, R., Kristinsson, S. Y., & Landgren, O. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0426 · Cited by 150
Palumbo, A., Gay, F., Cavallo, F., Di Raimondo, F., Larocca, A., Hardan, I., Nagler, A., Petrucci, M. T., Hajek, R., Pezzatti, S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.2466 · Cited by 150
Self-citationKastritis, E., Moulopoulos, L. A., Terpos, E., Koutoulidis, V., & Dimopoulos, M. A. (2014) · Leukemia · doi:10.1038/leu.2014.230 · Cited by 130
Meta-analyses of multiple myeloma and farming
Khuder, S., & Mutgi, A. B. (1997) · American Journal of Industrial Medicine · Cited by 130
Groen, R. W. J., Noort, W. A., Raymakers, R. A. P., Prins, H., Aalders, L., Hofhuis, F. M., Moerer, P., van Velzen, J. F., Bloem, A. C., van Kessel, B., et al. (2012) · Blood · doi:10.1182/blood-2012-03-414920 · Cited by 129
Guillerey, C., Nakamura, K., Vučković, S., Hill, G. R., & Smyth, M. J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2135-z · Cited by 128
Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?
Chrétien, M., Corre, J., Lauwers‐Cancès, V., Magrangeas, F., Cleynen, A., Yon, E., Hulin, C., Leleu, X. P., Orsini‐Piocelle, F., Blade, J., et al. (2015) · Blood · doi:10.1182/blood-2015-06-650242 · Cited by 121
Avet‐Loiseau, H., Hulin, C., Campion, L., Rodon, P., Marit, G., Attal, M., Royer, B., Dib, M., Voillat, L., Bouscary, D., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.2598 · Cited by 118
Heuck, C. J., Mehta, J., Bhagat, T. D., Gundabolu, K., Yu, Y., Khan, S. N., Chrysofakis, G., Schinke, C., Tariman, J. D., Vickrey, E., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202493 · Cited by 111
Kumar, A., Kharfan‐Dabaja, M. A., Glasmacher, A. G., & Djulbegović, B. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn439 · Cited by 103
Ross, F. M., Chiecchio, L., Dagrada, G. P., Protheroe, R. K. M., Stockley, D. M., Harrison, C. J., Cross, N. C. P., Szubert, A. J., Drayson, M. T., Morgan, G. J., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.016329 · Cited by 101
Huang, S., Yao, M., Tang, J., Lee, W., Tsay, W., Cheng, A., Wang, C., Chen, Y., Shen, M., & Tien, H. (2007) · Cancer · doi:10.1002/cncr.22850 · Cited by 100
The Cyclophilin A–CD147 complex promotes the proliferation and homing of multiple myeloma cells
Zhu, D., Wang, Z., Zhao, J., Calimeri, T., Jiang, M., Hideshima, T., Fulciniti, M., Kang, Y., Ficarro, S. B., Tai, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3867 · Cited by 100
Self-citationImpact of early relapse after auto-SCT for multiple myeloma
Kumar, S. K., Mahmood, S., Lacy, M. Q., Dispenzieri, A. A., Hayman, S. R., Buadi, F. K., Dingli, D., Rajkumar, S. V., Litzow, M. R., & Gertz, M. A. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.180 · Cited by 99
Self-citationTPL2 kinase regulates the inflammatory milieu of the myeloma niche
Hope, C. L., Ollar, S. J., Héninger, E., Hebron, E., Jensen, J. L., Kim, J., Maroulakou, I. G., Miyamoto, S., Leith, C. P., Yang, D. T., et al. (2014) · Blood · doi:10.1182/blood-2014-02-554071 · Cited by 98
Hébraud, B., Magrangeas, F., Cleynen, A., Lauwers‐Cancès, V., Chrétien, M., Hulin, C., Leleu, X. P., Yon, E., Marit, G., Karlin, L., et al. (2015) · Blood · doi:10.1182/blood-2014-07-587964 · Cited by 98
CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells
Walters, D. K., Arendt, B. K., & Jelinek, D. F. (2013) · Cell Cycle · doi:10.4161/cc.26193 · Cited by 86
CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease
Dairaghi, D. J., Oyajobi, B. O., Gupta, A., McCluskey, B., Miao, S., Powers, J. P., Seitz, L. C., Wang, Y., Zeng, Y., Zhang, P., et al. (2012) · Blood · doi:10.1182/blood-2011-10-384784 · Cited by 86
MUC1-C drives MYC in multiple myeloma
Tagde, A., Rajabi, H. N., Bouillez, A., Alam, M., Gali, R. R., Bailey, S. T., Tai, Y., Hideshima, T., Anderson, K. C., Avigan, D., et al. (2016) · Blood · doi:10.1182/blood-2015-07-659151 · Cited by 82
Self-citationBianchi, G., Kyle, R. A., Colby, C. L., Larson, D. R., Kumar, S. K., Katzmann, J. A., Dispenzieri, A. A., Therneau, T. M., Cerhan, J. R., Melton, L. J., et al. (2010) · Blood · doi:10.1182/blood-2010-04-277566 · Cited by 80
Self-citationStewart, A. K., Dimopoulos, M. A., Masszi, T., Špıčka, I., Oriol, A., Hájek, R., Rosiñol, L., Siegel, D. S. D., Niesvizky, R., Jakubowiak, A. J., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.9648 · Cited by 79
Altekruse, S. F., Henley, S. J., & Thun, M. J. (1999) · Cancer Causes & Control · doi:10.1023/a:1008926027805 · Cited by 76
DangER: protein ovERload. Targeting protein degradation to treat myeloma
Aronson, L. I., & Davies, F. E. (2012) · Haematologica · doi:10.3324/haematol.2012.064923 · Cited by 74
Hu, J., Valckenborgh, E. V., Menu, E., Bruyne, E. D., & Vanderkerken, K. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.008961 · Cited by 70
Gertz, M. A., Lacy, M. Q., Dispenzieri, A. A., Hayman, S. R., Kumar, S. K., Leung, N., & Gastineau, D. A. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705627 · Cited by 66
Self-citationInfections in Patients With Multiple Myeloma
Nucci, M., & Anaissie, E. J. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2009.03.006 · Cited by 56
Differential and limited expression of mutant alleles in multiple myeloma
Rashid, N. U., Sperling, A. S., Bolli, N., Wedge, D. C., Loo, P. V., Tai, Y., Shammas, M. A., Fulciniti, M., Samur, M., Richardson, P. G. G., et al. (2014) · Blood · doi:10.1182/blood-2014-04-569327 · Cited by 55
Self-citationCancer Cell Dissemination and Homing to the Bone Marrow in a Zebrafish Model
Sacco, A., Roccaro, A. M., Ma, D.-D., Shi, J., Mishima, Y., Moschetta, M., Chiarini, M., Munshi, N. C., Handin, R. I., & Ghobrial, I. M. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1926 · Cited by 52
Magrangeas, F., Kuiper, R., Avet‐Loiseau, H., Gouraud, W., Guérin‐Charbonnel, C., Ferrer, L., Aussem, A., Elghazel, H., Suhard, J., Sakissian, H. D., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-3163 · Cited by 51
Self-citationImmune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies
Ilcus, C., Bagacean, C., Tempescul, A., Popescu, C., Pârvu, A. V., Cenariu, M., Bocșan, I. C., & Zdrenghea, M. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s133385 · Cited by 50
Manier, S., Kawano, Y., Bianchi, G., Roccaro, A. M., & Ghobrial, I. M. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000259 · Cited by 47
Ziv, E., Dean, E. W., Hu, D., Martino, A., Serie, D., Curtin, K., Campa, D., Aftab, B. T., Bracci, P. M., Buda, G., et al. (2015) · Nature Communications · doi:10.1038/ncomms8539 · Cited by 45
Self-citationFrequent Engagement of RelB Activation Is Critical for Cell Survival in Multiple Myeloma
Cormier, F., Monjanel, H., Fabre, C., Billot, K., Sapharikas, E., Chéreau, F., Bordereaux, D., Molina, T. J., Avet‐Loiseau, H., & Baud, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059127 · Cited by 44
Knudsen, L. M., Rasmussen, T., Jensen, L., & Johnsen, H. E. (1999) · Medical Oncology · doi:10.1007/bf02785870 · Cited by 41
Concise Review: Defining and Targeting Myeloma Stem Cell‐Like Cells
Abe, M., Harada, T., & Matsumoto, T. (2014) · Stem Cells · doi:10.1002/stem.1643 · Cited by 37
Johnson, D. C., Weinhold, N., Mitchell, J. S., Chen, B., Kaiser, M., Begum, D. B., Hillengaß, J., Bertsch, U., Gregory, W. M., Cairns, D. A., et al. (2016) · Nature Communications · doi:10.1038/ncomms10290 · Cited by 32
Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?
Leiba, M., Duek, A., Amariglio, N., Avigdor, A., Benyamini, N., Hardan, I., Zilbershats, I., Ganzel, C., Shevetz, O., Novikov, I., et al. (2016) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22372 · Cited by 32
Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma
Sawyer, J. R., Tian, E., Shaughnessy, J. D., Epstein, J., Swanson, C. M., Stangeby, C., Hale, C. L., Parr, L. G., Lynn, M., Sammartino, G., et al. (2016) · Leukemia · doi:10.1038/leu.2016.253 · Cited by 32
Bone Disease in Multiple Myeloma
Eda, H., Santo, L., Roodman, G. D., & Raje, N. S. (2016) · Cancer treatment and research · doi:10.1007/978-3-319-40320-5_14 · Cited by 30
Epidemiology of Multiple Myeloma
Baris, D., Brown, L. M., Andreotti, G., & Devesa, S. S. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3764-2_28 · Cited by 27
Management of disease- and treatment-related complications in patients with multiple myeloma
Gay, F., & Palumbo, A. (2010) · Medical Oncology · doi:10.1007/s12032-010-9542-z · Cited by 25
Self-citationGonsalves, W. I., Rajkumar, S. V., Gertz, M. A., Dispenzieri, A. A., Lacy, M. Q., Buadi, F. K., Dingli, D., Go, R. S., Leung, N., Kapoor, P., et al. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.91 · Cited by 18
Self-citationBalduini, C. L., & Noris, P. (2015) · Haematologica · doi:10.3324/haematol.2015.138149 · Cited by 11
Genetic factors influencing the risk of multiple myeloma bone disease
Johnson, D. C., Weinhold, N., Mitchell, J. S., Chen, B., Stephens, O., Försti, A., Nickel, J., Kaiser, M., Gregory, W. M., Cairns, D. A., et al. (2015) · Leukemia · doi:10.1038/leu.2015.342 · Cited by 11
Moreau, P., Mary, J., & Attal, M. (2014) · British Journal of Haematology · doi:10.1111/bjh.13128 · Cited by 7
Weinhold, N., Chavan, S. S., Heuck, C. J., Stephens, O., Tytarenko, R. G., Bauer, M., Peterson, E. A., Ashby, T. C., Meißner, T., Stein, C. K., et al. (2015) · Blood · doi:10.1182/blood.v126.23.20.20 · Cited by 7
V. Smoldering multiple myeloma
Mateos, M., & Miguel, J. F. S. (2015) · Hematological Oncology · doi:10.1002/hon.2213 · Cited by 5
Self-citation
Cited by
Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment
Harjunpää, H., Llort Asens, M., Guenther, C., & Fagerholm, S. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01078 · Cited by 764
Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma
Chari, A., Minnema, M. C., Berdeja, J. G., Oriol, A., van de Donk, N. W. C. J., Rodríguez-Otero, P., Askari, E., Mateos, M.-V., Costa, L. J., Caers, J., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2204591 · Cited by 744
Self-citationAttal, M., Richardson, P. G., Rajkumar, S. V., San-Miguel, J., Beksac, M., Spicka, I., Leleu, X., Schjesvold, F., Moreau, P., Dimopoulos, M. A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32556-5 · Cited by 645
Self-citationSystemic immunoglobulin light chain amyloidosis
Merlini, G., Dispenzieri, A., Sanchorawala, V., Schönland, S. O., Palladini, G., Hawkins, P. N., & Gertz, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0034-3 · Cited by 552
Shah, N., Chari, A., Scott, E., Mezzi, K., & Usmani, S. Z. (2020) · Leukemia · doi:10.1038/s41375-020-0734-z · Cited by 490
Metadata
- Authors
- Kumar, S. K., Rajkumar, V., Kyle, R. A., van Duin, M., Sonneveld, P., Mateos, M.-V., Gay, F., & Anderson, K. C.
- Venue
- Nature Reviews Disease Primers
- Published
- 2017-07-20
- Volume
- 3
- Issue
- 1
- Pages
- 17046-17046
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4211058750
- Cited by
- 1,177
- References
- 153
- FWCI
- 16.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.